Use Caution with Implanted Pumps for Intrathecal Administration of Medicines for Pain Management: FDA Safety Communication

Use Caution with Implanted Pumps for Intrathecal Administration of Medicines for Pain Management: FDA Safety Communication

Today, the U.S. Food and Drug Administration issued a Safety Communication titled “Use Caution with Implanted Pumps for Intrathecal Administration of Medicines for Pain Management: FDA Safety Communication.” The FDA is sharing important information with health care providers, pharmacists, compounders, patients, and caregivers about the risks of using medications delivered into the spinal fluid to treat or manage pain that are not approved for use with the implanted pumps.   

The FDA Safety Communication is available on the FDA website.

If you have any questions, please contact the Center for Devices and Radiological Health’s Division of Industry and Consumer Education (DICE) at DICE@fda.hhs.gov, or by phone at 1-800-638-2041, or 301-796-7100.

Food and Drug Administration

Center for Devices and Radiological Health